Please use this identifier to cite or link to this item:
https://www.um.edu.mt/library/oar/handle/123456789/97001
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Agius, Edith | - |
dc.contributor.author | Bellizzi, Annalise | - |
dc.contributor.author | Rapa, Lara | - |
dc.contributor.author | Vassallo, Claire | - |
dc.date.accessioned | 2022-06-02T15:27:26Z | - |
dc.date.available | 2022-06-02T15:27:26Z | - |
dc.date.issued | 2022 | - |
dc.identifier.citation | Agius, E., Bellizzi, A., Rapa, L., & Vassallo, C. (2022). Lithium monitoring in clinical practice. Malta Medical Journal, 34(2), 59-64. | en_GB |
dc.identifier.uri | https://www.um.edu.mt/library/oar/handle/123456789/97001 | - |
dc.description.abstract | BACKGROUND: Lithium is widely used for the treatment of bipolar disorder. Owing to its narrow therapeutic index and side-effect profile, regular monitoring is recommended by all major guidelines on lithium use. | en_GB |
dc.description.abstract | AIMS: The aim of this study was to determine whether routine lithium monitoring practice at the local mental hospital in Malta reaches the standard set by the NICE guidelines in 2014. | en_GB |
dc.description.abstract | METHOD: All patients on lithium maintenance treatment for bipolar disorder at the local Mental Hospital were included. Blood tests within the last one year were collected using iSOFT clinical manager (iCM). After the first audit cycle, a lithium monitoring sheet was created in accordance with the NICE guideline and after 6 months of implementation, the second audit cycle was conducted. | en_GB |
dc.description.abstract | RESULTS: In the first cycle, 28 patients met the NICE criteria for increased risk of toxicity and have a recommended testing frequency for lithium levels of every 3 months. However, only 1 patient was observed to meet this criteria. When assessing the last lithium level only 35.7% were within 0.4-0.8 mmol/L. In the second audit cycle, 28 patients met the NICE criteria for increased risk of toxicity and have a recommended testing frequency for lithium levels of every 3 months. Almost half of the patients (12 patients, 42%) were to observed to meet this criteria. When assessing the last lithium level, 50% were within 0.4-0.8 mmol/L. | en_GB |
dc.description.abstract | CONCLUSIONS: The introduction on the lithium monitoring sheet improved monitoring substantially especially in high risk patients. Moreover, the majority of test results for lithium levels were within the therapeutic range. | en_GB |
dc.language.iso | en | en_GB |
dc.publisher | University of Malta. Medical School | en_GB |
dc.rights | info:eu-repo/semantics/openAccess | en_GB |
dc.subject | Lithium -- Therapeutic use | en_GB |
dc.subject | Lithium -- Physiological effect | en_GB |
dc.subject | Lithium -- Side effects | en_GB |
dc.subject | Drug monitoring | en_GB |
dc.title | Lithium monitoring in clinical practice | en_GB |
dc.type | article | en_GB |
dc.rights.holder | The copyright of this work belongs to the author(s)/publisher. The rights of this work are as defined by the appropriate Copyright Legislation or as modified by any successive legislation. Users may access this work and can make use of the information contained in accordance with the Copyright Legislation provided that the author must be properly acknowledged. Further distribution or reproduction in any format is prohibited without the prior permission of the copyright holder. | en_GB |
dc.description.reviewed | peer-reviewed | en_GB |
dc.publication.title | Malta Medical Journal | en_GB |
Appears in Collections: | MMJ, Volume 34, Issue 2 MMJ, Volume 34, Issue 2 |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
MMJ34(2)A7.pdf | 515.56 kB | Adobe PDF | View/Open |
Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.